Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Madrigal Pharmaceuticals, Inc. - Common Stock (NQ: MDGL )

326.79 +6.86 (+2.14%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 397,351
Open 315.76
Bid (Size) 305.00 (3)
Ask (Size) 330.00 (1)
Prev. Close 319.93
Today's Range 313.52 - 329.57
52wk Range 189.00 - 377.46
Shares Outstanding 17,103,395
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Workday, ACM Research, ZoomInfo Technologies, CEVA, Intuit And Other Big Stocks Moving Higher On Wednesday
Via Benzinga

Performance

YTD
+4.15%
+4.15%
1 Month
-4.81%
-4.81%
3 Month
-3.92%
-3.92%
6 Month
+60.99%
+60.99%
1 Year
+59.68%
+59.68%

More News

Read More
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Madrigal Pharmaceuticals Stock Jumps On New Two-Year Data Showing Potential Benefit of Rezdiffra For Compensated Fatty Liver Cirrhosis
Via Benzinga
Why Madrigal Pharmaceuticals Stock Is Soaring Today
Via The Motley Fool
Earnings Scheduled For February 26, 2025
Via Benzinga
Why Madrigal Pharmaceuticals Stock Is Sinking Today
Via The Motley Fool
8 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Why Madrigal Pharmaceuticals Stock Was Plummeting This Week
Via The Motley Fool
Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
Via MarketBeat
Top 3 Health Care Stocks That May Dip This Month
Via Benzinga
Billionaire Ken Griffin Invested $93 Million of Citadel's Portfolio in a Stock That Could Rocket 105% Higher, According to a Wall Street Analyst
Via The Motley Fool
Earnings Preview For Madrigal Pharmaceuticals
Via Benzinga
3 Reasons Why Buying Madrigal Pharmaceuticals Today Is a Wise Move
Via The Motley Fool
MDGL: A Promising Play In The Weight Loss Drug Space
Via Talk Markets
Topics Stocks / Equities
1 Growing Biotech Stock to Buy Today With $1,000 and Hold for 5 Years or More
Via The Motley Fool
Apple Satellite Connectivity Provider Globalstar And Timberland Parent V.F Corp Are Among Top 7 Mid Cap Gainers Last Week (Oct 28-Nov 1): Are The Others In Your Portfolio?
Via Benzinga
Madrigal Catapults After Novo's Wegovy Proves It's No 'Silver Bullet' In MASH
Via Investor's Business Daily
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Is Madrigal Pharmaceuticals Stock a Buy?
Via The Motley Fool
This 1 Setback for Novo Nordisk Is Bullish for Madrigal Pharmaceuticals Stock
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Biotech Stocks: Why Acadia Pharma And Others Are Feeling 'Growing Pains'
Via Investor's Business Daily
Topics Earnings
Exposures Financial
Is It Too Late to Buy Madrigal Pharmaceuticals Stock?
Via The Motley Fool
7 Biotech Stocks to Keep on Your Clinical Radar
Via InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.